The Spock of Cannabis
Plan Now or Fail Later: Why Raw Materials Matter
Accelerating the development of mRNA vaccines and therapeutics requires the selection and use of raw materials designed to meet critical process, scale, quality and regulatory needs. Choosing appropriate materials saves scientists both time and money.
Cannabis Standardization: Product Quality Specification and Certification Programs Are Finally Here
Join David Vaillencourt, CEO, The GMP Collective and Darwin Millard, The Spock of Cannabis in this free webinar which will provide an update on cannabis standardization from ASTM and what the future has in store.